Detection Technology Oy · OMXHEX:DETEC
Detection Technology Oy — Q1 2025 Earnings Presentation
13 slides from Detection Technology Oy's earnings presentation, Apr 24, 2025
Slide 1: Q1 Business review January–March 2025
Q1 Business review January–March 2025 President and CEO Hannu Martola | 24 April 2025
Slide 2: Q1 2025 net sales and EBITA
Q1 2025 22.2 -2.0 1.4 6.3 net sales, €m net sales change-% EBITA, €m EBITA-% (22.7) (-0.2) (2.3) (10.0) 2 24.4.2025 Detection Technology | Business review January—March 2025 presentation
Slide 3: Growth in medical
Growth in medical The Q1 outcome, in the big picture, as expected Exchange rate changes at the end of the quarter led to a slight decline in total net sales Industrial sales +4% • Driven by significant growth in TFT flat panel detectors Medical sales +14% • Returned to growth in China, where unmet d
Slide 4: Net sales by quarter
Net sales by quarter (EUR 1,000) 35,000 30,000 25,000 20,000 -2.0 15,000 (YOY change-%) 10,000 5,000 0 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 2022 2023 2024 2025 4 24.4.2025 Detection Technology | Business review January—March 2025 presentation
Slide 5: Operating margin (EBITA) excluding NRI
Operating margin (EBITA) excluding NRI (EUR 1,000) 6,000 25% 5,000 20% 4,000 16.3% 15.3% 15% 14.8% 3,000 12.7% 10.0% 9.9% 10% 9.0% 2,000 7.4% 6.3% 6.5% 5.2% 5.4% 5% 1,000 2.3% 0 0% Q122 Q222 Q322 Q422 Q123 Q223 Q323 Q423 Q124 Q224 Q324 Q424 Q125 EBITA excluding NRI (EUR 1,000) EBITA-% excluding NRI
Slide 6: Q1 2025 sales split by regional business units
Q1 2025 sales split by regional business units NET SALES €m YOY CHANGE-% 3.9% 24.3% AMERICAS 0.9 -3.9 TOTAL NET SALES 22.2 €m APAC 16.0 2.1 71.8% EMEIA 5.4 -12.2 6 24.4.2025 Detection Technology | Business review January—March 2025 presentation
Slide 7: Q1 2025 sales split by main applications
Q1 2025 sales split by main applications NET SALES €m YOY CHANGE-% INDUSTRIAL 3.8 4.2 16.9% 34.4% TOTAL NET SALES 22.2 €m MEDICAL 10.8 13.7 48.7% SECURITY 7.7 -20.0 7 24.4.2025 Detection Technology | Business review January—March 2025 presentation
Slide 8: Key figures
Key figures Q1 2025 Q1 2024 FY 2024 Net sales, EUR 1,000 22,249 22,706 107,514 Change in net sales, % -2.0% -0.2% 3.6% EBITA, EUR 1,000 1,399 2,263 14,892 EBITA, % 6.3% 10.0% 13.9% R&D costs, EUR 1,000 2,634 2,512 11,379 R&D costs, % of net sales 11.8% 11.1% 10.6% Cash flow from operating activities
Slide 9: Main events
Main events Launched a lead-free flat panel detector, X-Panel 2520z FOM, for dental imaging • First in the market features advanced IGZO-TFT technology at the size of 25 cm x 20 cm Started pre-sales of XL-sized a-Si-TFT flat panel detector optimized for high-energy industrial NDT applications Progre
Slide 10: Sales expectation Q2 and Q3 2025
Sales expectation Q2 and Q3 2025 Industrial Medical Security to grow to grow to decline in Q2 in Q2 in Q2 Sales in APAC and Americas to grow, and in EMEIA to decline in Q2 YOY total net sales to be stable in Q2 and Q3 2025 10 24.4.2025 Detection Technology | Business review January—March 2025 presen
Slide 11: Business outlook
Business outlook SECURITY MARKET annual growth rate Detection Technology expects its year-on-year total net sales to remain stable in Q2 and 5% Q3 of 2025. Detection Technology has refined its earlier estimate of double-digit total net sales growth for Q2 2025 (published on 6 February 2025) and INDU
Slide 12: Financial targets
FINANCIAL TARGETS MEDIUM TERM Annual MEDIUM TERM Operating ANNUAL Dividend or sales growth margin (EBITA) returned capital >10% 15% 30-60% 12 24.4.2025 Detection Technology | Business review January—March 2025 presentation
Slide 13: www.deetee.com
Detection Technology